Citigroup
CNST

Citigroup’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Citigroup’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-496,548
Closed -$16.8M – 6561
2021
Q2 		$16.8M Buy
496,548
+358,727
+260% +$9.14M 0.01% 1096
2021
Q1 		$3.22M Buy
137,821
+129,061
+1,473% +$3.91M ﹤0.01% 2142
2020
Q4 		$252K Buy
8,760
+3,220
+58% +$81.1K ﹤0.01% 4812
2020
Q3 		$112K Sell
5,540
-17,220
-76% -$420K ﹤0.01% 5039
2020
Q2 		$684K Buy
22,760
+16,241
+249% +$585K ﹤0.01% 3936
2020
Q1 		$205K Buy
6,519
+3,420
+110% +$119K ﹤0.01% 4715
2019
Q4 		$146K Buy
3,099
+2,256
+268% +$65.1K ﹤0.01% 5439
2019
Q3 		$5K Sell
843
-3,446
-80% -$28.8K ﹤0.01% 7367
2019
Q2 		$53K Buy
4,289
+59
+1% +$657 ﹤0.01% 6427
2019
Q1 		$57K Buy
4,230
+3,167
+298% +$28.4K ﹤0.01% 6238
2018
Q4 		$4K Sell
1,063
-66
-6% -$398 ﹤0.01% 7420
2018
Q3 		$8K Buy
+1,129
New +$10.8K ﹤0.01% 7424

Citigroup's CNST Position: Q3 2021 in Review

Citigroup sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 496,548 shares — an estimated $16.8M sold.

Citigroup first reported a position in CNST in Q3 2018 and held it in 12 quarters. The position peaked at $16.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Citigroup reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 496,548 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $16.8M.
  • Citigroup first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
  • Citigroup's Constellation Pharmaceuticals, Inc. position peaked at $16.8M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.